10.1038/s41423-022-00934-6 96 JoshiD
These medications can cause a rollercoaster of side effects at different stages of treatment
GLP-1 therapies influence pathways tied to addiction and reward, according to the Endocrine Society A randomized clinical trial published in JAMA Psychiatry found semaglutide reduced alcohol cravings and consumption Users commonly report: Reduced desire to drink Feeling full faster when drinking Less reward from alcohol The data: early, but directionally consistent While long-term industry sales data is still developing, the early signals from clinical studies, observational research, and population polling all point in the same direction: GLP-1 use is associated with lower alcohol consumption for at least some users
JCI Insight (2022)
When injecting, go slowly and steadily, keeping the needle still while its in your skin
Drawing from both lived experience and years of patient care, she outlines how mold exposure can trigger mast cell activation, autoimmunity, and complex chronic illness